The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
A Research Agenda for Malaria Eradication: Drugs
Open accessAbstract
Antimalarial drugs will be essential tools at all stages of malaria elimination along the path towards eradication, including the early control or "attack" phase to drive down transmission and the later stages of maintaining interruption of transmission, preventing reintroduction of malaria, and eliminating the last residual foci of infection. Drugs will continue to be used to treat acute malaria illness and prevent complications in vulnerable groups, but better drugs are needed for elimination-specific indications such as mass treatment, curing asymptomatic infections, curing relapsing liver stages, and preventing transmission. The ideal malaria eradication drug is a coformulated drug combination suitable for mass administration that can be administered in a single encounter at infrequent intervals and that results in radical cure of all life cycle stages of all five malaria species infecting humans. Short of this optimal goal, highly desirable drugs might have limitations such as targeting only one or two parasite species, the priorities being Plasmodium falciparum and Plasmodium vivax. The malaria research agenda for eradication should include research aimed at developing such drugs and research to develop situation-specific strategies for using both current and future drugs to interrupt malaria transmission.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Artemisinin Resistance in Plasmodium falciparum Malaria
Dondorp, A. M., Nosten, F., Yi, P., Das, D., Phyo, A. P., Tarning, J., Lwin, K. M., Ariey, F., Hanpithakpong, W., Lee, S. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808859 · Cited by 3,424
Evidence of Artemisinin-Resistant Malaria in Western Cambodia
Noedl, H., Se, Y., Schaecher, K., Smith, B. L., Socheat, D., & Fukuda, M. M. (2008) · New England Journal of Medicine · doi:10.1056/nejmc0805011 · Cited by 1,785
Plasmodium knowlesi Malaria in Humans Is Widely Distributed and Potentially Life Threatening
Cox-Singh, J., Davis, T. M. E., Lee, K.-S., Shamsul, S. S. G., Matusop, A., Ratnam, S., Rahman, H. A., Conway, D. J., & Singh, B. (2008) · Clinical Infectious Diseases · doi:10.1086/524888 · Cited by 886
Vivax Malaria: Neglected and Not Benign
Price, R. N., Tjitra, E., Guerra, C. A., Yeung, S., White, N. J., & Anstey, N. M. (2007) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2007.77.79 · Cited by 838
Artemisinin resistance: current status and scenarios for containment
Dondorp, A. M., Yeung, S., White, L., Nguon, C., Day, N. P. J., Socheat, D., & von Seidlein, L. (2010) · Nature Reviews Microbiology · doi:10.1038/nrmicro2331 · Cited by 645
Ruwende, C., Khoo, S. C., Snow, R. W., Yates, S. N. R., Kwiatkowski, D., Gupta, S., Warn, P., Allsopp, C. E. M., Gilbert, S. C., Peschu, N., et al. (1995) · Nature · doi:10.1038/376246a0 · Cited by 595
Chemotherapy and drug resistance in malaria
Peters, W. (1970) · Medical Entomology and Zoology · Cited by 551
Molineaux, L., & Gramiccia, G. (1980) · Medical Entomology and Zoology · Cited by 416
White, N. J., & Olliaro, P. L. (1996) · Parasitology Today · doi:10.1016/0169-4758(96)10055-7 · Cited by 307
Bruce-Chwatt, L. J. (1981) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/0035-9203(81)90085-7 · Cited by 286
Cited by
A Research Agenda to Underpin Malaria Eradication
Alonso, P. L., Brown, G., Arevalo-Herrera, M., Binka, F., Chitnis, C., Collins, F., Doumbo, O. K., Greenwood, B., Hall, B. F., Levine, M. M., et al. (2011) · PLoS Medicine · doi:10.1371/journal.pmed.1000406 · Cited by 667
The medicinal chemistry of ferrocene and its derivatives
Patra, M., & Gasser, G. (2017) · Nature Reviews Chemistry · doi:10.1038/s41570-017-0066 · Cited by 609
Howes, R. E., Piel, F. B., Patil, A. P., Nyangiri, O. A., Gething, P. W., Dewi, M., Hogg, M. M., Battle, K. E., Padilla, C. D., Baird, J. K., et al. (2012) · PLoS Medicine · doi:10.1371/journal.pmed.1001339 · Cited by 562
New developments in anti-malarial target candidate and product profiles
Burrows, J. N., Duparc, S., Gutteridge, W. E., Hooft van Huijsduijnen, R., Kaszubska, W., Macintyre, F., Mazzuri, S., Möhrle, J. J., & Wells, T. N. C. (2017) · Malaria Journal · doi:10.1186/s12936-016-1675-x · Cited by 520
Characterizing, controlling and eliminating residual malaria transmission
Killeen, G. F. (2014) · Malaria Journal · doi:10.1186/1475-2875-13-330 · Cited by 506
A novel multiple-stage antimalarial agent that inhibits protein synthesis
Baragaña, B., Hallyburton, I., Lee, M. C. S., Norcross, N. R., Grimaldi, R., Otto, T. D., Proto, W. R., Blagborough, A. M., Meister, S., Wirjanata, G., et al. (2015) · Nature · doi:10.1038/nature14451 · Cited by 454
Targeting Plasmodium PI(4)K to eliminate malaria
McNamara, C. W., Lee, M. C. S., Lim, C. S., Lim, S. H., Roland, J., Nagle, A., Simon, O., Yeung, B. K. S., Chatterjee, A. K., McCormack, S. L., et al. (2013) · Nature · doi:10.1038/nature12782 · Cited by 431
Malaria medicines: a glass half full?
Wells, T. N. C., van Huijsduijnen, R. H., & Van Voorhis, W. C. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4573 · Cited by 430
Beyond insecticides: new thinking on an ancient problem
McGraw, E. A., & O'Neill, S. L. (2013) · Nature Reviews Microbiology · doi:10.1038/nrmicro2968 · Cited by 381
Antimalarial drug discovery — approaches and progress towards new medicines
Flannery, E. L., Chatterjee, A. K., & Winzeler, E. A. (2013) · Nature Reviews Microbiology · doi:10.1038/nrmicro3138 · Cited by 313
Hemingway, J., Shretta, R., Wells, T. N. C., Bell, D., Djimdé, A. A., Achee, N., & Qi, G. (2016) · PLOS Biology · doi:10.1371/journal.pbio.1002380 · Cited by 293
Quinolone-3-Diarylethers: A New Class of Antimalarial Drug
Nilsen, A., LaCrue, A. N., White, K. L., Forquer, I. P., Cross, R. M., Marfurt, J., Mather, M. W., Delves, M. J., Shackleford, D. M., Saenz, F. E., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3005029 · Cited by 292
Designing the next generation of medicines for malaria control and eradication
Burrows, J. N., Hooft van Huijsduijnen, R., Möhrle, J. J., Oeuvray, C., & Wells, T. N. (2013) · Malaria Journal · doi:10.1186/1475-2875-12-187 · Cited by 282
Robinson, L. J., Wampfler, R., Betuela, I., Karl, S., White, M. T., Li Wai Suen, C. S. N., Hofmann, N. E., Kinboro, B., Waltmann, A., Brewster, J., et al. (2015) · PLOS Medicine · doi:10.1371/journal.pmed.1001891 · Cited by 276
A Research Agenda for Malaria Eradication: Vaccines
The malERA Consultative Group on Vaccines (2011) · PLoS Medicine · doi:10.1371/journal.pmed.1000398 · Cited by 264
Oral, ultra–long-lasting drug delivery: Application toward malaria elimination goals
Bellinger, A. M., Jafari, M., Grant, T. M., Zhang, S., Slater, H. C., Wenger, E. A., Mo, S., Lee, Y.-A. L., Mazdiyasni, H., Kogan, L., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aag2374 · Cited by 262
malERA: An updated research agenda for malaria elimination and eradication
Rabinovich, R. N., Drakeley, C., Djimde, A. A., Hall, B. F., Hay, S. I., Hemingway, J., Kaslow, D. C., Noor, A., Okumu, F., Steketee, R., et al. (2017) · PLOS Medicine · doi:10.1371/journal.pmed.1002456 · Cited by 261
Biology of Malaria Transmission
Meibalan, E., & Marti, M. (2017) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a025452 · Cited by 251
Snider, D., & Weathers, P. J. (2021) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2020.113638 · Cited by 23
Metadata
- Authors
- The malERA Consultative Group on Drugs
- Venue
- PLoS Medicine
- Publisher
- Public Library of Science (PLoS)
- Published
- 2011-01-25
- Volume
- 8
- Issue
- 1
- Pages
- e1000402
- ISSN
- 1549-1277 (ISSN-L)
- 1549-1676
- OpenAlex
- W2154882650
- Cited by
- 288
- References
- 33
- FWCI
- 44.69
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.